Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06203691 · ClinicalTrials.gov registry record · NA

Nirvana Super Pro Supplementation in Orthopedic Surgery Patients

A NA study of Arthropathy of Knee and Arthropathy of Hip, sponsored by Nirvana Water Sciences.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06203691 is a NA study of Arthropathy of Knee and Arthropathy of Hip that is actively recruiting participants, run by Nirvana Water Sciences. The registered enrollment target is 100 participants, above the 77-participant average among 6 other Arthropathy of Knee trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06203691, a NA study of Arthropathy of Knee and Arthropathy of Hip, is actively recruiting participants, sponsored by Nirvana Water Sciences.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate orthopedic patients undergoing either a total hip replacement (THR) or total knee arthroplasty (TKR) using two dietary supplements, PREPARE and RECOVER, and their recovery times post-surgery.

Interventions

  • DIETARY_SUPPLEMENT Supplementation with Nirvana Super Pro Liquid Supplements
  • DIETARY_SUPPLEMENT Non-Supplementation Group

Study Locations (1)

Pennsylvania

  • University Orthopedics Center - Altoona

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-02-21
Est. Completion 2024-08-30
Phase NA

Sponsor

Nirvana Water Sciences

1 total trials

What the Registry Record Tells You About NCT06203691

The ClinicalTrials.gov registry entry for NCT06203691 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 77-participant average among 6 other Arthropathy of Knee trials with a reported enrollment target (30% higher). The listed sponsor is Nirvana Water Sciences, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Arthropathy of Knee appearing as the primary indexed condition, and to 2 interventions - of which Supplementation with Nirvana Super Pro Liquid Supplements is the first listed.

NCT06203691 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06203691 about?

NCT06203691 is a clinical study titled "Nirvana Super Pro Supplementation in Orthopedic Surgery Patients". The purpose of this study is to investigate orthopedic patients undergoing either a total hip replacement (THR) or total knee arthroplasty (TKR) using two dietary supplements, PREPARE and RECOVER, and their recovery times post-surgery.

What is the current status of trial NCT06203691?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-02-21. Estimated completion is 2024-08-30.

What conditions does trial NCT06203691 study?

This clinical trial studies the following conditions: Arthropathy of Knee, Arthropathy of Hip.

What interventions are being tested in trial NCT06203691?

The interventions under investigation include: Supplementation with Nirvana Super Pro Liquid Supplements (DIETARY_SUPPLEMENT), Non-Supplementation Group (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06203691?

This trial is sponsored by Nirvana Water Sciences, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06203691 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthropathy of Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.